Coherus BioSciences, Inc. (CHRS) stock analysis and AI prediction
The company facts of Coherus BioSciences, Inc., with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Coherus BioSciences, Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $83.2 million
- Size
- Micro cap
- Employees
- 145
- Headquarters
- REDWOOD CITY, CA
- Listed since
- Nov. 6, 2014
- Website
- coherus.com
More Healthcare stocks
Other micro cap stocks
Keep going
CHRS questions
What is the AI prediction for CHRS stock?
Each market day our model rates Coherus BioSciences, Inc. (CHRS) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the CHRS prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for CHRS?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see CHRS options?
The CHRS options page opens its calls and puts, with price, volume, implied volatility and the Greeks.